Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer White

Showing results (121-130 of 184) with videos related to

Pageof 19
Sort By:
JACC. Cardiovascular Imaging|August 20, 2018
The Impact of a Rigorous Quality Program on 3D Echocardiography Data Quality in an International Multisite Randomized TrialAnna Lisa Crowley, Eric Yow, Dawn Rabineau, et al.
American Heart Journal|July 31, 2013
Results of a reevaluation of cardiovascular outcomes in the RECORD trialKenneth W Mahaffey, Gail Hafley, Sheila Dickerson, et al.
American Heart Journal|July 31, 2013
Methodology of a reevaluation of cardiovascular outcomes in the RECORD trial: study design and conductRenato D Lopes, Sheila Dickerson, Gail Hafley, et al.
Protein Science : a Publication of the Protein Society|August 24, 2004
Biological activity, membrane-targeting modification, and crystallization of soluble human decay accelerating factor expressed in E. coliJennifer White, Petra Lukacik, Dirk Esser, et al.
Implementation Science : IS|May 4, 2019
A novel counterbalanced implementation study design: methodological description and application to implementation researchMitchell N Sarkies, Elizabeth H Skinner, Kelly-Ann Bowles, et al.
Dementia (London, England)|July 16, 2023
The MINDSET Study: Co-Designing Training for Interpreters in Dementia and Cognitive AssessmentsAndrew S Gilbert, Josefine Antoniades, Kerry Hwang, et al.
Journal of the American College of Cardiology|September 19, 2003
Angiographic variables predict increased risk for adverse ischemic events after coronary stenting with glycoprotein IIb/IIIa inhibition: results from the TARGET trialMitchell J Ross, Howard C Herrmann, David J Moliterno, et al.
Blood|December 3, 2005
Protection of erythrocytes from human complement-mediated lysis by membrane-targeted recombinant soluble CD59: a new approach to PNH therapyAnita Hill, Simon H Ridley, Dirk Esser, et al.
Transplantation and Cellular Therapy|December 2, 2022
A Multicenter, Retrospective Study Evaluating Clinical Outcomes of Ruxolitinib Therapy In Heavily Pretreated Chronic GVHD Patients With Steroid FailureJennifer White, Mohamed Elemary, Swe Mar Linn, et al.
Circulation|September 24, 2019
Effect of Once-Weekly Exenatide in Patients With Type 2 Diabetes Mellitus With and Without Heart Failure and Heart Failure-Related Outcomes: Insights From the EXSCEL TrialMarat Fudim, Jennifer White, Neha J Pagidipati, et al.
Pageof 19

Showing results (121-130 of 184) with videos related to

Sort By:
Pageof 19
JACC. Cardiovascular Imaging|August 20, 2018
The Impact of a Rigorous Quality Program on 3D Echocardiography Data Quality in an International Multisite Randomized TrialAnna Lisa Crowley, Eric Yow, Dawn Rabineau, et al.
American Heart Journal|July 31, 2013
Results of a reevaluation of cardiovascular outcomes in the RECORD trialKenneth W Mahaffey, Gail Hafley, Sheila Dickerson, et al.
American Heart Journal|July 31, 2013
Methodology of a reevaluation of cardiovascular outcomes in the RECORD trial: study design and conductRenato D Lopes, Sheila Dickerson, Gail Hafley, et al.
Protein Science : a Publication of the Protein Society|August 24, 2004
Biological activity, membrane-targeting modification, and crystallization of soluble human decay accelerating factor expressed in E. coliJennifer White, Petra Lukacik, Dirk Esser, et al.
Implementation Science : IS|May 4, 2019
A novel counterbalanced implementation study design: methodological description and application to implementation researchMitchell N Sarkies, Elizabeth H Skinner, Kelly-Ann Bowles, et al.
Dementia (London, England)|July 16, 2023
The MINDSET Study: Co-Designing Training for Interpreters in Dementia and Cognitive AssessmentsAndrew S Gilbert, Josefine Antoniades, Kerry Hwang, et al.
Journal of the American College of Cardiology|September 19, 2003
Angiographic variables predict increased risk for adverse ischemic events after coronary stenting with glycoprotein IIb/IIIa inhibition: results from the TARGET trialMitchell J Ross, Howard C Herrmann, David J Moliterno, et al.
Blood|December 3, 2005
Protection of erythrocytes from human complement-mediated lysis by membrane-targeted recombinant soluble CD59: a new approach to PNH therapyAnita Hill, Simon H Ridley, Dirk Esser, et al.
Transplantation and Cellular Therapy|December 2, 2022
A Multicenter, Retrospective Study Evaluating Clinical Outcomes of Ruxolitinib Therapy In Heavily Pretreated Chronic GVHD Patients With Steroid FailureJennifer White, Mohamed Elemary, Swe Mar Linn, et al.
Circulation|September 24, 2019
Effect of Once-Weekly Exenatide in Patients With Type 2 Diabetes Mellitus With and Without Heart Failure and Heart Failure-Related Outcomes: Insights From the EXSCEL TrialMarat Fudim, Jennifer White, Neha J Pagidipati, et al.
Pageof 19